|
🐜
|
Empagliflozin in Patients with Chronic Kidney Disease
39 auth.
W. Herrington,
N. Staplin,
C. Wanner,
J. B. Green,
S. Hauske,
J. Emberson,
D. Preiss,
P. Judge,
Kaitlin J. Mayne,
S. Ng,
E. Sammons,
D. Zhu,
M. Hill,
W. Stevens,
K. Wallendszus,
...
S. Brenner,
A. Cheung,
Zhi-Hong Liu,
Jing Li,
L. Hooi,
Wen Liu,
T. Kadowaki,
M. Nangaku,
A. Levin,
D. Cherney,
A. Maggioni,
R. Pontremoli,
R. Deo,
S. Goto,
X. Rosselló,
K. Tuttle,
D. Steubl,
M. Petrini,
D. Massey,
Jens Eilbracht,
M. Brueckmann,
M. Landray,
C. Baigent,
R. Haynes
|
9 |
2022 |
9
🐜
|
|
🐜
|
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
38 auth.
C. Baigent,
J. Emberson,
R. Haynes,
W. Herrington,
P. Judge,
M. Landray,
Kaitlin J. Mayne,
S. Ng,
D. Preiss,
A. Roddick,
N. Staplin,
D. Zhu,
S. Anker,
Deepak L. Bhatt,
M. Brueckmann,
...
J. Butler,
D. Cherney,
Jennifer B. Green,
S. Hauske,
H. Heerspink,
S. Inzucchi,
M. Jardine,
Chih-Chin Liu,
K. Mahaffey,
Finnian R. McCausland,
D. McGuire,
J. McMurray,
B. Neal,
B. Neuen,
M. Packer,
V. Perkovic,
M. Sabatine,
S. Solomon,
M. Vaduganathan,
C. Wanner,
D. Wheeler,
S. Wiviott,
F. Zannad
|
8 |
2022 |
8
🐜
|
|
🐜
|
Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic Epidemiology
14 auth.
N. Staplin,
W. Herrington,
F. Murgia,
M. Ibrahim,
Katherine R. Bull,
P. Judge,
S. Ng,
Michael Turner,
D. Zhu,
J. Emberson,
...
M. Landray,
C. Baigent,
R. Haynes,
J. Hopewell
|
3 |
2022 |
3
🐜
|
|
🐜
|
Correlates of chronic hepatitis B virus infection in the general adult population of China: Systematic review and meta‐analysis
12 auth.
Elizabeth M Hamilton,
Wadie Rassam,
Yan Yan,
Avjit Singh,
S. Ng,
Jiabi Zhang,
...
J. Lv,
N. Islam,
R. Malouf,
Ling Yang,
I. Millwood,
Zhengming Chen
|
3 |
2023 |
3
🐜
|
|
🐜
|
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease
40 auth.
W. Herrington,
N. Staplin,
Nikita Agrawal,
C. Wanner,
Jennifer B Green,
S. Hauske,
J. Emberson,
David Preiss,
P. Judge,
D. Zhu,
R. Dayanandan,
R. Arimoto,
Kaitlin J. Mayne,
S. Ng,
E. Sammons,
...
M. Hill,
W. Stevens,
K. Wallendszus,
S. Brenner,
Alfred K. Cheung,
Zhi-hong Liu,
Jing Li,
L. Hooi,
Wen Liu,
T. Kadowaki,
M. Nangaku,
A. Levin,
D. Cherney,
Aldo P. Maggioni,
R. Pontremoli,
R. Deo,
S. Goto,
X. Rossello,
Katherine R. Tuttle,
D. Steubl,
D. Massey,
Martina Brueckmann,
M. Landray,
C. Baigent,
Richard Haynes
|
1 |
2024 |
1
🐜
|
|
🐜
|
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors
14 auth.
D. Chapman,
P. Judge,
R. Sardell,
N. Staplin,
T. Arnold,
D. Zhu,
S. Ng,
S. Moffatt,
M. Landray,
C. Baigent,
...
M. Hill,
R. Haynes,
S. Clark,
W. Herrington
|
1 |
2022 |
1
🐜
|
|
🦁
|
Haemodialysis, blood pressure and risk: at the limit of non-randomized evidence.
S. Ng,
R. Haynes,
W. Herrington
|
0 |
2020 |
0
🦁
|
|
🦁
|
Associations Between Blood Pressure (BP) and Risk of CKD: A Clinically Adjudicated Study of 0.5 Million Chinese Adults
14 auth.
S. Ng,
R. Sardell,
Peiling Chen,
Guang Chen,
Jingjing Wang,
Shuiqin Cheng,
Wenjing Fan,
Xia Liu,
Zhengming Chen,
Zhihong Liu,
...
Yiping Chen,
C. Baigent,
Natalie Staplin,
W. Herrington
|
0 |
2022 |
0
🦁
|
